Ställberg, BjörnTeixeira, PedroBlom, CoertLisspers, KarinTsiligianni, IoannaJordan, RachelRomán-Rodríguez, MiguelKleefstra, NanneKorzh, OleksiiPrice, DavidChavannes, Niels2016-11-252016-11-252016-11-17Ställberg, B, Teixeira, P, Blom, C, Lisspers, K, Tsiligianni, I, Jordan, R, Román-Rodríguez, M, Kleefstra, N, Korzh, O, Price, D & Chavannes, N 2016, 'The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients : a protocol for an UNLOCK study from the IPCRG', npj Primary Care Respiratory Medicine, vol. 26, 16069. https://doi.org/10.1038/npjpcrm.2016.69http://hdl.handle.net/2164/7749Funding The IPCRG provided funding for this research project as an UNLOCK Group study for which the funding was obtained through an unrestricted grant by Novartis AG, Basel, Switzerland. Novartis has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study will include data from the Optimum Patient Care Research Database, and is undertaken in collaboration with Optimum Patient Care and the Respiratory Effectiveness Group, which will provide the data for this initiative without charge to the UNLOCK Group.243402engSDG 3 - Good Health and Well-beingchronic obstructive pulmonary diseasemedical researchR MedicineRJournal article10.1038/npjpcrm.2016.6926